About BIOLABO GROUP
Year of Establishment: 1986
BIOLABO manufactures reagents for medical biology and offers three ranges of reagents: biochemistry, coagulation and slide tests to aid the diagnosis of major pandemic diseases, cardiovascular disorders, diabetes, hepatitis, and obesity. BIOLABO reagents are well known for their very long shelf life, stability, linearity and reliability. Following the acquisition of BPC BioSed in 2016, BIOLABO is among the very few manufacturers controlling the production of both reagents and analyzers, and ships 97% of its production to its highly organized distribution network comprising more than 80 distributors in various countries.